Mezzion Pharma Co.Ltd - Asset Resilience Ratio

Latest as of September 2025: 13.09%

Mezzion Pharma Co.Ltd (140410) has an Asset Resilience Ratio of 13.09% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Mezzion Pharma Co.Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

₩11.50 Billion

≈ $7.79 Million USD Cash + Short-term Investments

Total Assets

₩87.88 Billion

≈ $59.56 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Mezzion Pharma Co.Ltd's Asset Resilience Ratio has changed over time. See Mezzion Pharma Co.Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Mezzion Pharma Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 140410 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩11.50 Billion	13.09%
Total Liquid Assets	₩11.50 Billion	13.09%

Asset Resilience Insights

Moderate Liquidity: Mezzion Pharma Co.Ltd has 13.09% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Mezzion Pharma Co.Ltd Industry Peers by Asset Resilience Ratio

Compare Mezzion Pharma Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	4.82%
ST Pharm Co.Ltd KQ:237690	Pharmaceuticals	7.72%
Oscotec Inc KQ:039200	Pharmaceuticals	61.00%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%
NatureCell Co.Ltd KQ:007390	Pharmaceuticals	0.00%
Kolon Life Science Inc KQ:102940	Pharmaceuticals	1.22%
Huons Global Co. Ltd KQ:084110	Pharmaceuticals	5.46%
Komipharm International Co. Ltd KQ:041960	Pharmaceuticals	2.23%

Annual Asset Resilience Ratio for Mezzion Pharma Co.Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Mezzion Pharma Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	38.67%	₩28.62 Billion ≈ $19.39 Million	₩74.00 Billion ≈ $50.15 Million	-24.54pp
2023-12-31	63.21%	₩58.25 Billion ≈ $39.47 Million	₩92.15 Billion ≈ $62.45 Million	+3.24pp
2022-12-31	59.97%	₩32.40 Billion ≈ $21.96 Million	₩54.02 Billion ≈ $36.61 Million	+3.73pp
2021-12-31	56.24%	₩47.21 Billion ≈ $31.99 Million	₩83.93 Billion ≈ $56.88 Million	-8.68pp
2020-12-31	64.93%	₩49.10 Billion ≈ $33.28 Million	₩75.63 Billion ≈ $51.25 Million	-4.98pp
2019-12-31	69.91%	₩41.16 Billion ≈ $27.89 Million	₩58.87 Billion ≈ $39.90 Million	-0.18pp
2018-12-31	70.09%	₩52.61 Billion ≈ $35.65 Million	₩75.06 Billion ≈ $50.87 Million	+0.23pp
2017-12-31	69.86%	₩51.72 Billion ≈ $35.05 Million	₩74.04 Billion ≈ $50.17 Million	+3.08pp
2016-12-31	66.77%	₩64.04 Billion ≈ $43.40 Million	₩95.90 Billion ≈ $64.99 Million	+44.36pp
2015-12-31	22.42%	₩23.10 Billion ≈ $15.66 Million	₩103.05 Billion ≈ $69.84 Million	--

pp = percentage points

About Mezzion Pharma Co.Ltd

KQ:140410 Korea Pharmaceuticals

Market Cap

$477.82 Million

₩705.07 Billion KRW

Market Cap Rank

#12837 Global

#411 in Korea

Share Price

₩82500.00

Change (1 day)

-4.51%

52-Week Range

₩36400.00 - ₩172700.00

All Time High

₩172700.00